Table 2.
No. of patients (%) | |
---|---|
Indication for bronchoscopy: | |
Mediastinal/hilar lymphadenopathy | 39 (38%) |
Pulmonary mass or nodules | 37 (36%) |
Chronic infiltrate | 20 (20%) |
Endobronchial lesion/stricture | 3 (3%) |
Hemoptysis | 2 (2%) |
Tracheomalacia | 1 (1%) |
Total | 102 |
Post-bronchoscopy diagnosis: | |
Primary or metastatic pulmonary lung cancer | 52 (51%) |
Indeterminate diagnosis or unknown | 28 (27%) |
Sarcoidosis | 14 (14%) |
Nonspecific interstitial lung disease or Interstitial lung fibrosis | 5 (5%) |
Aseptic organizing pneumonia | 2 (2%) |
Wegener granulomatosis | 1 (1%) |
Total | 102 |
Other: | |
Presence of documented COPDa | 26 (25%) |
Active or recentb smoker | 41 (40%) |
Documentation of COPD obtained from pre-bronchoscopy evaluation in medical record; authors suspect prevalence of COPD in study population to be higher than documented.
Recent smoker defined as smoking within the previous 10 years of bronchoscopy.